Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Chemotherapy Induced Peripheral Neuropathy Treatment market will register a 6.6%% CAGR in terms of revenue, the global market size will reach $ 1866.1 million by 2025, from $ 1445.2 million in 2019. In particular, this report presents the global revenue market share of key companies in Chemotherapy Induced Peripheral Neuropathy Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Chemotherapy Induced Peripheral Neuropathy Treatment market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Chemotherapy Induced Peripheral Neuropathy Treatment, covering the supply chain analysis, impact assessment to the Chemotherapy Induced Peripheral Neuropathy Treatment market size growth rate in several scenarios, and the measures to be undertaken by Chemotherapy Induced Peripheral Neuropathy Treatment companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Calcium Channel α2-delta Ligands
Antidepressants
Opioids
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Platinum Agents
Taxanes
Vinca Alkaloids
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Aptinyx Inc
Kineta Inc
Asahi Kasei Pharma Corp
MAKScientific LLC
Metys Pharmaceuticals AG
Regenacy Pharmaceuticals
Sova Pharmaceuticals Inc
Nemus Bioscience Inc
DermaXon LLC
PledPharma
Krenitsky Pharmaceuticals Inc
WinSanTor
Apexian Pharma
Solasia Pharma K.K.
PeriphaGen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Chemotherapy Induced Peripheral Neuropathy Treatment market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Chemotherapy Induced Peripheral Neuropathy Treatment market by identifying its various subsegments.
Focuses on the key global Chemotherapy Induced Peripheral Neuropathy Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chemotherapy Induced Peripheral Neuropathy Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Chemotherapy Induced Peripheral Neuropathy Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2015-2025
2.1.2 Chemotherapy Induced Peripheral Neuropathy Treatment Market Size CAGR by Region
2.2 Chemotherapy Induced Peripheral Neuropathy Treatment Segment by Type
2.2.1 Calcium Channel α2-delta Ligands
2.2.2 Calcium Channel α2-delta Ligands
2.2.3 Opioids
2.2.4 Others
2.3 Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type
2.3.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type (2015-2020)
2.3.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth Rate by Type (2015-2020)
2.4 Chemotherapy Induced Peripheral Neuropathy Treatment Segment by Application
2.4.1 Platinum Agents
2.4.2 Taxanes
2.4.3 Vinca Alkaloids
2.4.4 Others
2.5 Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application
2.5.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application (2015-2020)
2.5.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth Rate by Application (2015-2020)
3 Global Chemotherapy Induced Peripheral Neuropathy Treatment by Players
3.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Players
3.1.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Players (2018-2020)
3.1.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Players (2018-2020)
3.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Chemotherapy Induced Peripheral Neuropathy Treatment by Regions
4.1 Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Regions
4.2 Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth
4.3 APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth
4.4 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth
4.5 Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth
5 Americas
5.1 Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Countries
5.2 Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type
5.3 Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Regions
6.2 APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type
6.3 APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Chemotherapy Induced Peripheral Neuropathy Treatment by Countries
7.2 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type
7.3 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment by Countries
8.2 Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type
8.3 Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast
10.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Forecast (2021-2025)
10.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Forecast by Regions
10.2.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Chemotherapy Induced Peripheral Neuropathy Treatment Forecast by Type
10.8 Global Chemotherapy Induced Peripheral Neuropathy Treatment Forecast by Application
11 Key Players Analysis
11.1 Aptinyx Inc
11.1.1 Company Details
11.1.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.1.3 Aptinyx Inc Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Aptinyx Inc News
11.2 Kineta Inc
11.2.1 Company Details
11.2.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.2.3 Kineta Inc Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Kineta Inc News
11.3 Asahi Kasei Pharma Corp
11.3.1 Company Details
11.3.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.3.3 Asahi Kasei Pharma Corp Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Asahi Kasei Pharma Corp News
11.4 MAKScientific LLC
11.4.1 Company Details
11.4.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.4.3 MAKScientific LLC Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 MAKScientific LLC News
11.5 Metys Pharmaceuticals AG
11.5.1 Company Details
11.5.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.5.3 Metys Pharmaceuticals AG Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Metys Pharmaceuticals AG News
11.6 Regenacy Pharmaceuticals
11.6.1 Company Details
11.6.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.6.3 Regenacy Pharmaceuticals Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Regenacy Pharmaceuticals News
11.7 Sova Pharmaceuticals Inc
11.7.1 Company Details
11.7.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.7.3 Sova Pharmaceuticals Inc Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Sova Pharmaceuticals Inc News
11.8 Nemus Bioscience Inc
11.8.1 Company Details
11.8.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.8.3 Nemus Bioscience Inc Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Nemus Bioscience Inc News
11.9 DermaXon LLC
11.9.1 Company Details
11.9.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.9.3 DermaXon LLC Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 DermaXon LLC News
11.10 PledPharma
11.10.1 Company Details
11.10.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
11.10.3 PledPharma Chemotherapy Induced Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 PledPharma News
11.11 Krenitsky Pharmaceuticals Inc
11.12 WinSanTor
11.13 Apexian Pharma
11.14 Solasia Pharma K.K.
11.15 PeriphaGen
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Chemotherapy Induced Peripheral Neuropathy Treatment Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Calcium Channel α2-delta Ligands
Table 5. Major Players of Antidepressants
Table 6. Major Players of Opioids
Table 7. Major Players of Others
Table 8. Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type (2015-2020)
Table 10. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application (2015-2020)
Table 12. Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share by Players (2018-2020)
Table 14. Global Chemotherapy Induced Peripheral Neuropathy Treatment Key Players Head office and Products Offered
Table 15. Chemotherapy Induced Peripheral Neuropathy Treatment Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Regions 2015-2020
Table 20. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Countries (2015-2020)
Table 22. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type (2015-2020)
Table 24. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application (2015-2020)
Table 26. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Regions (2015-2020)
Table 28. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type (2015-2020)
Table 30. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application (2015-2020)
Table 32. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Countries (2015-2020)
Table 34. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type (2015-2020)
Table 36. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Chemotherapy Induced Peripheral Neuropathy Treatment
Table 45. Key Application and Potential Industries of Chemotherapy Induced Peripheral Neuropathy Treatment
Table 46. Key Challenges of Chemotherapy Induced Peripheral Neuropathy Treatment
Table 47. Key Trends of Chemotherapy Induced Peripheral Neuropathy Treatment
Table 48. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share Forecast by Regions
Table 50. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share Forecast by Application (2021-2025)
Table 54. Aptinyx Inc Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 55. Aptinyx Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 56. Aptinyx Inc Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 57. Aptinyx Inc Main Business
Table 58. Aptinyx Inc Latest Developments
Table 59. Kineta Inc Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 60. Kineta Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 61. Kineta Inc Main Business
Table 62. Kineta Inc Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 63. Kineta Inc Latest Developments
Table 64. Asahi Kasei Pharma Corp Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 65. Asahi Kasei Pharma Corp Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 66. Asahi Kasei Pharma Corp Main Business
Table 67. Asahi Kasei Pharma Corp Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 68. Asahi Kasei Pharma Corp Latest Developments
Table 69. MAKScientific LLC Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 70. MAKScientific LLC Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 71. MAKScientific LLC Main Business
Table 72. MAKScientific LLC Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 73. MAKScientific LLC Latest Developments
Table 74. Metys Pharmaceuticals AG Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 75. Metys Pharmaceuticals AG Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 76. Metys Pharmaceuticals AG Main Business
Table 77. Metys Pharmaceuticals AG Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 78. Metys Pharmaceuticals AG Latest Developments
Table 79. Regenacy Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 80. Regenacy Pharmaceuticals Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 81. Regenacy Pharmaceuticals Main Business
Table 82. Regenacy Pharmaceuticals Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 83. Regenacy Pharmaceuticals Latest Developments
Table 84. Sova Pharmaceuticals Inc Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 85. Sova Pharmaceuticals Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 86. Sova Pharmaceuticals Inc Main Business
Table 87. Sova Pharmaceuticals Inc Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 88. Sova Pharmaceuticals Inc Latest Developments
Table 89. Nemus Bioscience Inc Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 90. Nemus Bioscience Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 91. Nemus Bioscience Inc Main Business
Table 92. Nemus Bioscience Inc Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 93. Nemus Bioscience Inc Latest Developments
Table 94. DermaXon LLC Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 95. DermaXon LLC Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 96. DermaXon LLC Main Business
Table 97. DermaXon LLC Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 98. DermaXon LLC Latest Developments
Table 99. PledPharma Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 100. PledPharma Chemotherapy Induced Peripheral Neuropathy Treatment Product Offered
Table 101. PledPharma Main Business
Table 102. PledPharma Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Gross Margin (2018-2020E)
Table 103. PledPharma Latest Developments
Table 104. Krenitsky Pharmaceuticals Inc Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 105. WinSanTor Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 106. Apexian Pharma Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 107. Solasia Pharma K.K. Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
Table 108. PeriphaGen Details, Company Total Revenue (in $ million), Head Office, Chemotherapy Induced Peripheral Neuropathy Treatment Major Market Areas and Its Competitors
List of Figures
Figure 1. Chemotherapy Induced Peripheral Neuropathy Treatment Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type (2015-2020)
Figure 5. Global Calcium Channel α2-delta Ligands Market Size Growth Rate
Figure 6. Global Antidepressants Market Size Growth Rate
Figure 7. Global Opioids Market Size Growth Rate
Figure 8. Global Others Market Size Growth Rate
Figure 9. Chemotherapy Induced Peripheral Neuropathy Treatment in Platinum Agents
Figure 10. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market: Platinum Agents (2015-2020) ($ Millions)
Figure 11. Chemotherapy Induced Peripheral Neuropathy Treatment in Taxanes
Figure 12. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market: Taxanes (2015-2020) ($ Millions)
Figure 13. Chemotherapy Induced Peripheral Neuropathy Treatment in Vinca Alkaloids
Figure 14. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market: Vinca Alkaloids (2015-2020) ($ Millions)
Figure 15. Global Vinca Alkaloids YoY Growth ($ Millions)
Figure 16. Chemotherapy Induced Peripheral Neuropathy Treatment in Others
Figure 17. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market: Others (2015-2020) ($ Millions)
Figure 18. Global Others YoY Growth ($ Millions)
Figure 19. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application in 2019
Figure 20. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Regions 2015-2020
Figure 21. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2015-2020 ($ Millions)
Figure 22. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2015-2020 ($ Millions)
Figure 23. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2015-2020 ($ Millions)
Figure 24. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2015-2020 ($ Millions)
Figure 25. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Countries in 2019
Figure 26. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type in 2019
Figure 27. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application in 2019
Figure 28. United States Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 29. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 30. Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 31. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Regions in 2019
Figure 32. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type in 2019
Figure 33. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application in 2019
Figure 34. China Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 35. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 36. Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 37. Southeast Asia Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 38. India Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 39. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 40. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Countries in 2019
Figure 41. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type in 2019
Figure 42. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application in 2019
Figure 43. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 44. France Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 45. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 46. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 47. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 48. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 49. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Countries in 2019
Figure 50. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Type in 2019
Figure 51. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Market Share by Application in 2019
Figure 52. Egypt Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 53. South Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 54. Israel Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 55. Turkey Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 56. GCC Countries Chemotherapy Induced Peripheral Neuropathy Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 57. Global Chemotherapy Induced Peripheral Neuropathy Treatment arket Size Forecast (2021-2025) ($ Millions)
Figure 58. Americas Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 59. APAC Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 60. Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 61. Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 62. United States Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 63. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 64. Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 65. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 66. China Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 67. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 68. Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 69. Southeast Asia Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 70. India Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 71. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 72. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 73. France Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 74. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 75. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 76. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 77. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 78. Egypt Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 79. South Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 80. Israel Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 81. Turkey Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Figure 82. GCC Countries Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets